Fox Chase Cancer Center doctors are not just clinical specialists—they’re also world-renowned cancer researchers. The results of studies conducted by Fox Chase doctors have been crucial in advancing our understanding of lymphoma diagnosis and treatment around the world.
In addition to the latest treatments for advanced lymphoma, Fox Chase is actively developing and evaluating a number of new therapies, often before they are available anywhere else. We offer clinical trials to patients with most subtypes of lymphoma, either at diagnosis or at relapse. Some lymphomas are characterized by genetic mutations that activate cancer pathways. There are therapies available that can target specific pathways for lymphoma patients. Another focus of our lymphoma team is the treatment of patients with T cell lymphoma, including cutaneous T cell lymphomas. Immunotherapy can activate the patient’s own immune system to fight the lymphoma.
We encourage eligible patients to participate in clinical trials that are available and appropriate for their stage and type of lymphoma.
